|| Diagnosis of monocytic AML (age 5), by the Department of Pediatric Oncohematology of Policlinico San Matteo of Pavia;
|| Chemotherapy for the diagnosed AML, according to the modified AIEOP LAM 92 protocol;
|| Diagnosis of medullary recidivism (age 6) refractory to the above chemotherapy protocol upon its re-introduction;
|| Allogenic bone marrow transplantation from an HLA-adequate donor (the patient’s brother), after conditioning via busulfan, cyclophosphamide, and melphalan administration;
|| Diagnosis of new recidivism at the rear-peritoneal abdominal level (age 7);
|| Allogenic bone marrow transplantation from patient’s brother, after a myeloablative treatment via total-body irradiation combined with cyclophosphamide and thiotepa;
|| Diagnosis of AML-free (age 18) after reaching the 10-year disease-free checkpoint.